What are the most common side effects of SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE?

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Is SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE the same as its brand-name version?

SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE is the generic name. The active ingredient is the same across any brand-name or generic versions approved by the FDA.

SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE

Q: What is SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE used for?

SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE is a CNS Stimulant indicated for weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions ( 5.7 ), weight loss) than patients 6 years and older at the same dosage (5.7, 8.4)..

Q: How does SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE work?

SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE works through the following mechanism: 12.1 Mechanism of Action Serdexmethylphenidate is a prodrug of dexmethylphenidate. Dexmethylphenidate HCl is a central nervous system (CNS) stimulant. The mode of therapeutic action in ADHD is not known..

CNS Stimulant

Oral

Mechanism of Action

12.1 Mechanism of Action Serdexmethylphenidate is a prodrug of dexmethylphenidate. Dexmethylphenidate HCl is a central nervous system (CNS) stimulant. The mode of therapeutic action in ADHD is not known.

Indications

weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions ( 5.7 )

weight loss) than patients 6 years and older at the same dosage (5.7

8.4).

Contraindications

• 4 CONTRAINDICATIONS AZSTARYS is contraindicated in patients: with known hypersensitivity to serdexmethylphenidate
• methylphenidate
• or other components of AZSTARYS. Bronchospasm
• rash
• or within 14 days following discontinuation of treatment with an MAOI

FDA Warnings

5 WARNINGS AND PRECAUTIONS Risks to Patients with Serious Cardiac Disease : Avoid use in patients with known structural cardiac abnormalities, cardiomyopathy, serious cardiac arrhythmias, coronary artery disease, or other serious cardiac disease
3) Psychiatric Adverse Reactions : Prior to initiating AZSTARYS, screen patients for risk factors for developing a manic episode
7) Acute Angle Closure Glaucoma : AZSTARYS-treated patients considered at risk for acute angle closure glaucoma (e
8) Increased Intraocular Pressure (IOP) and Glaucoma : Prescribe AZSTARYS to patients with open-angle glaucoma or abnormally increased IOP only if the benefit of treatment is considered to outweigh the risk

Known Side Effects

8 documented side effects by frequency

Drug Not Working

>10%

Anxiety

1-10%

Headache

1-10%

Insomnia

1-10%

Decreased Appetite

1-10%

Nausea

1-10%

Fatigue

1-10%

Depression

0.1-1%

Community Discussions

No community discussions found for SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE yet.

Primary sources

Every figure on this page links back to its primary source. See data sources for full provenance.

DailyMed FDA label search → SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE openFDA label JSON → SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE FAERS adverse-event reports → SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE ClinicalTrials.gov → completed Phase 2+ trials of SERDEXMETHYLPHENIDATE AND DEXMETHYLPHENIDATE

Compare With

14 available comparisons

Formulations

Dosage Forms

Tablet

Route

Oral